The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials
Kilitch Drugs India Limited, a leading manufacturer of Injectables in India starts production of the Cephalosporin Injectables at the Ethiopia manufacturing plant.
The company had started its greenfield project in Ethiopia in 2018 to build a world-class Injectable plant. The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials. Through this plant most of the capacity is going to be sold in Ethiopia through the government and other institutes.
Mukund Mehta, Chairman & Managing Director, Kilitch Drugs said, “Africa has always been our focus market for our products. We have started this manufacturing plant to cater to the African markets directly as there very few injectable manufacturing plants in the whole continent and in turn help the people of Africa. Also, there is more demand than supply in Ethiopia so we see that this has good business opportunities.”
Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2023 on 13-14 July 2023, Novotel Mumbai International Airport, Mumbai
Tamilnadu Petroproducts gets India's First BIS certification under IS 12795: 2020 for high-quality LAB Production
Creating policy and regulatory frameworks could accelerate the green hydrogen ecosystem: B. S. Bhalla
Subscribe To Our Newsletter & Stay Updated